The group reported substantial sales, profits and earnings growth, all at record levels. Before on...
The group reported substantial sales, profits and earnings growth, all at record levels. Before one-off costs profit before tax was up 79% and sales by over 60% as the company focused on the speciality pharmaceuticals sector and its acquisition of the French pharma business, Martindale. Following this acquisition the group has divided its activities into pharmaceutical distribution and manufacturing. As well as strong organic growth, the group will continue to look for further significantly sized acquisitions in the UK and overseas.
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes